Have a personal or library account? Click to login
An Unusual Cause of Camptocormia Cover

An Unusual Cause of Camptocormia

Tremor and Other Hyperkinetic Movements
Volume 9 (2019): Issue 0
By: Sahil Mehta,  Rajender Kumar and  Vivek Lal  
Open Access
|Feb 2019

References

  1. 1
    AzherSNJankovicJCamptocormia: pathogenesis, classification, and response to therapyNeurology20056535535910.1212/01.wnl.0000171857.09079.9f16087897
    Back to article
  2. 2
    AliFMatsumotoJYHassanACamptocormia: etiology, diagnosis and treatment responseNeurol Clin Pract2018824024810.1212/CPJ.000000000000045330105164
    Back to article
  3. 3
    MargrafNGWredeADeuschlGSchulz-SchaefferWJPathophysiological concepts and treatment of camptocormiaJ Parkinsons Dis2016648550110.3233/JPD-16083627314757
    Back to article
  4. 4
    BertramKLStripePColosimoCTreatment of camptocormia with botulinum toxinToxicon2015107(Pt A)14815310.1016/j.toxicon.2015.06.00426079953
    Back to article
  5. 5
    LyonsMBoucherOPatelNBirchBEvidenteVLong-term benefit of bilateral subthalamic deep brain stimulation on camptocormia in Parkinson’s diseaseTurk Neurosurg20122248949210.5137/1019-5149.JTN.3857-10.022843472
    Back to article
  6. 6
    ShinHWKimMJKimMSLeeMCChungSJLevosulpiride induced movement disordersMov Disord20092422495310.1002/mds.2280519795476
    Back to article
  7. 7
    MargrafNGWredeARohrASchulz- SchaefferWJRaethjenJEymessAet alCamptocormia in idiopathic Parkinson’s disease: a focal myopathy of the paravertebral musclesMov Disord20102554255110.1002/mds.2278020108372
    Back to article
  8. 8
    MathewTNadimpallyUSPrabhuADNadigRDrug-induced Parkinsonism on the rise: beware of levosulpiride and its combinations with proton pump inhibitorsNeurol India20176517317410.4103/0028-3886.19817528084264
    Back to article
  9. 9
    AquinoCCLangAETardive dyskinesia syndromes: current conceptsParkinsonism Relat Disord201420S11311710.1016/S1353-8020(13)70028-224262160
    Back to article
  10. 10
    HauserRATruongDTardive dyskinesia: out of the shadowsJ Neurol Sci20183891310.1016/j.jns.2018.02.00929449008
    Back to article
  11. 11
    DolzanVPlesnicarBKSerretti, MandelliLZalarBKoprivsekJBreskvarKPolymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatmentAm J Med Genet B Neuropsychiatr Genet2007144B80981510.1002/ajmg.b.3054417455212
    Back to article
  12. 12
    WilffertBAI HadithyAFSinghVJMatroosGHoekHWvan OSJet alThe role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study 1XJ Psychopharmacol20092365265910.1177/026988110809159418562401
    Back to article
  13. 13
    Lopez-SendonJMenaMAde YebenesJGDrug-induced parkinsonismExpert Opin Drug Saf20131248749610.1517/14740338.2013.78706523540800
    Back to article
  14. 14
    KiriakakisVBhatiaKPQuinnNPMarsdenCDThe natural history of tardive dystonia. A long-term follow-up study of 107 casesBrain1998121(Pt 11)2053206610.1093/brain/121.11.20539827766
    Back to article
DOI: https://doi.org/10.5334/tohm.492 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Oct 1, 2018
Accepted on: Nov 13, 2018
Published on: Feb 13, 2019
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Levosulpiride,
camptocormia,
parkinsonism

© 2019 Sahil Mehta, Rajender Kumar, Vivek Lal, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.

Previous articleVolume 9 (2019): Issue 0Next article